Glomerular C4d deposition indicates in situ classic complement pathway activation, but is not a marker for lupus nephritis activity

被引:21
作者
Kim, SH [1 ]
Jeong, HJ [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Pathol, Seodaemun Gu, Seoul 120752, South Korea
关键词
lupus nephritis; C4d; activity index(AI);
D O I
10.3349/ymj.2003.44.1.75
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study was designed to evaluate whether glomerular C4d deposition may be a useful marker of lupus nephritis activity. Twenty-one patients diagnosed as having lupus nephritis (WHO class III: 4 cases; IV: 12 cases; V: 5 cases) were included. Mean patient age was 29.3 +/- 13.5 years (range: 7-55 years). The presence and intensity of glomerular C4d deposition were compared with the corresponding histologic activity index for each case. Immunofluorescence for C4d showed diffusely granular staining along glomerular capillary loops, in all cases examined (1+, in 8 cases; 2+, in 7 cases; 3+, in 6cases). In eight cases, C4d deposition was found in the absence of capillary or mesangial C4 deposits. Moreover, the intensity of C4d deposits correlated with those of capillary IgG, IgA, C4, C1q, and fibrinogen deposits. However, C4d staining intensity did not correlate with the lupus nephritis activity index. Although glomerular capillary C4d deposition is a sensitive marker of classic complement pathway activation, it is not a sensitive marker for active lupus nephritis.
引用
收藏
页码:75 / 80
页数:6
相关论文
共 31 条
[1]  
Abraham M A, 1999, J Assoc Physicians India, V47, P862
[2]  
AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75
[3]   COMPLEMENT ACTIVATION DURING SYSTEMIC LUPUS-ERYTHEMATOSUS - C3A AND C5A ANAPHYLATOXINS CIRCULATE DURING EXACERBATIONS OF DISEASE [J].
BELMONT, HM ;
HOPKINS, P ;
EDELSON, HS ;
KAPLAN, HB ;
LUDEWIG, R ;
WEISSMANN, G ;
ABRAMSON, S .
ARTHRITIS AND RHEUMATISM, 1986, 29 (09) :1085-1089
[4]   ASSESSMENT OF DISEASE-ACTIVITY AND IMPENDING FLARE IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - COMPARISON OF THE USE OF COMPLEMENT SPLIT PRODUCTS AND CONVENTIONAL MEASUREMENTS OF COMPLEMENT [J].
BUYON, JP ;
TAMERIUS, J ;
BELMONT, HM ;
ABRAMSON, SB .
ARTHRITIS AND RHEUMATISM, 1992, 35 (09) :1028-1037
[5]   AMINO-ACID-SEQUENCE AROUND THE THIOL AND REACTIVE ACYL-GROUPS OF HUMAN-COMPLEMENT COMPONENT-C4 [J].
CAMPBELL, RD ;
GAGNON, J ;
PORTER, RR .
BIOCHEMICAL JOURNAL, 1981, 199 (02) :359-370
[6]  
Collins AB, 1999, J AM SOC NEPHROL, V10, P2208
[7]   RADIOIMMUNOASSAY OF THE ATTACK COMPLEX OF COMPLEMENT IN SERUM FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
FALK, RJ ;
DALMASSO, AP ;
KIM, Y ;
LAM, S ;
MICHAEL, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (25) :1594-1599
[8]   The humoral immune response towards HLA class II determinants in renal transplantation [J].
Feucht, HE ;
Opelz, G .
KIDNEY INTERNATIONAL, 1996, 50 (05) :1464-1475
[9]   THE TERMINAL COMPLEMENT COMPLEX, C5B-9, A MARKER OF DISEASE-ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
GAWRYL, MS ;
CHUDWIN, DS ;
LANGLOIS, PF ;
LINT, TF .
ARTHRITIS AND RHEUMATISM, 1988, 31 (02) :188-195
[10]   USE OF SINGLE VOIDED URINE SAMPLES TO ESTIMATE QUANTITATIVE PROTEINURIA [J].
GINSBERG, JM ;
CHANG, BS ;
MATARESE, RA ;
GARELLA, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (25) :1543-1546